Medical Doctor Program year 2022 Reported 2019–2022 Source: CMS Open Payments, 2026 publication

Diana Pollock

Neurology Clearwater, FL Medical Doctor

NPI 1609825942 CMS profile 72309

430 Morton Plant St, Suite 400, Clearwater, FL 33756

Open in the dashboard

General payments

$15,770

398 records reported · program years 2019–2022

Research payments

$2,500

Paid to them · 1 record reported · program years 2019–2022

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$13,870 paid to institutions, not to them · program years 2019–2020

Through program year 2022, Diana Pollock of Clearwater, FL is reported in the CMS Open Payments database as having received $15,770 across 398 general payments and $2,500 in research payments paid to them. Separately, studies naming them as principal investigator received $13,870 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 82nd percentile of Neurology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2022 General $30 2
2021 General $3,471 104
2020 General $10,141 157
2020 Research $2,500 1
2019 General $2,128 135

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Diana Pollock
  • Neurology median
  • Middle half of Neurology
  • National median

In program year 2025, general payments to Diana Pollock were reported at $0. Among 11,022 Neurology profiles paid that year, the median was $457 and the middle half received between $118 and $2,344.

Show as a table
Year Diana Pollock Neurology median Middle half National median
2019 $2,128 $474 $118–$2,177 $163
2020 $10,141 $367 $82–$2,309 $114
2021 $3,471 $438 $104–$2,547 $132
2022 $30 $442 $103–$2,388 $149
2023 $0 $464 $119–$2,312 $160
2024 $0 $468 $119–$2,323 $164
2025 $0 $457 $118–$2,344 $169

Breakdown

Who paid General payments · program years 2019–2022
  1. Allergan Inc. $9,567 74 payments
  2. Biogen, Inc. $943 2 payments
  3. Sunovion Pharmaceuticals Inc. $415 28 payments
  4. Teva Pharmaceuticals USA, Inc. $363 28 payments
  5. ACADIA Pharmaceuticals Inc $350 24 payments
  6. Upsher-Smith Laboratories LLC $321 14 payments
  7. Novartis Pharmaceuticals Corporation $269 14 payments
  8. Amgen Inc. $264 15 payments
  9. Eisai Inc. $260 15 payments
  10. Avanir Pharmaceuticals, Inc. $259 15 payments
  11. Other $2,758 169 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2022
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $7,594 5 payments
  2. Food and Beverage $6,538 387 payments
  3. Consulting Fee $930 1 payment
  4. Travel and Lodging $708 5 payments
Products named General payments · program years 2019–2022
  1. UBRELVY Neuroscience $7,051 25 payments
  2. UBRELVY Neuroscience $1,917 12 payments
  3. BOTOX $751 47 payments
  4. AIMOVIG $516 28 payments
  5. NUPLAZID $350 24 payments
  6. APTIOM $335 24 payments
  7. Fycompa $260 15 payments
  8. NUEDEXTA $259 15 payments
  9. NURTEC ODT $244 19 payments
  10. EMGALITY $183 13 payments
  11. Other $3,365 191 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2022
  1. Harmony Biosciences LLC $2,500 1 payment

Records

399 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2022

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record